semaglutide approval for mash Novo Nordisk's Wegovy Approved Treatment in India, ETPharma FDA Approval Expands Novo Nordisk's

Ultimately, initiating GLP-1 therapy before full thyroid optimization is a clinical judgment call that should weigh the urgency of metabolic control against the risk of confusing the symptoms or destabilizing thyroid function

Healthcare providers may consider: Bacterial culture if infection is suspected Temporary discontinuation of semaglutide to assess symptom resolution Referral to allergy/immunology for suspected hypersensitivity reactions For type 2 diabetes patients only, alternative GLP-1 receptor agonist formulations (such as oral semaglutide/Rybelsus) if injection site reactions are recurrent and problematic Patients with confirmed hypersensitivity to semaglutide should not continue the medication

Individual differences: The duration of B12 injection benefits can also vary based on individual factors, such as age, genetics, and overall health status

Proprioceptive training, progressive loading exercises, and neuromuscular control work remain essential for full functional recovery